Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
35,975,445
-
Share change
-
-2,437,546
-
Total reported value
-
$15,748,087
-
Price per share
-
$0.44
-
Number of holders
-
32
-
Value change
-
-$1,108,648
-
Number of buys
-
11
-
Number of sells
-
10
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q4 2018
As of 31 Dec 2018,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,975,445 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, Fosun International Ltd, ORBIMED ADVISORS LLC, MORGAN STANLEY, ETF MANAGERS GROUP, LLC, Opaleye Management Inc., Sectoral Asset Management Inc, Benchmark Capital Advisors, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.